Lemaitre Vascular (LMAT) Tops Q3 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $81.26 +0.40%
EPS Growth %: +11.3%
Financial Fact:
Sales and marketing: 6.54M
Today's EPS Names:
LTBR, AES, SYRS, More
EPS Growth %: +11.3%
Financial Fact:
Sales and marketing: 6.54M
Today's EPS Names:
LTBR, AES, SYRS, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q3 EPS of $0.25, $0.05 better than the analyst estimate of $0.20. Revenue for the quarter came in at $24.8 million versus the consensus estimate of $25.47 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Calix, Inc. (CALX) Tops Q3 EPS by 3c; offers guidance
- Inspire Medical Systems (INSP) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 Guidance
- Waystar Holding Corp. (WAY) Reports Q3 EPS of $0.44
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
